The circulating sphingosine-1-phosphate level predicts incident fracture in postmenopausal women: a 3.5-year follow-up observation study
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The circulating sphingosine-1-phosphate level predicts incident fracture in postmenopausal women: a 3.5-year follow-up observation study
Authors
Keywords
Biomarker, Bisphosphonate, Insufficient response, Osteoporotic fracture, Sphingosine-1-phosphate
Journal
OSTEOPOROSIS INTERNATIONAL
Volume 27, Issue 8, Pages 2533-2541
Publisher
Springer Nature
Online
2016-03-19
DOI
10.1007/s00198-016-3565-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy
- (2015) Richard L. Proia et al. JOURNAL OF CLINICAL INVESTIGATION
- Fracture mortality: associations with epidemiology and osteoporosis treatment
- (2014) Sebastian E. Sattui et al. Nature Reviews Endocrinology
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Postmenopausal Osteoporosis
- (2013) Nelson Watts et al. Endocrine Practice
- Efficacy of intravenously administered ibandronate in postmenopausal Korean women with insufficient response to orally administered bisphosphonates
- (2012) Sung Jin Bae et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Plasma Sphingosine 1-Phosphate Levels and the Risk of Vertebral Fracture in Postmenopausal Women
- (2012) Beom-Jun Kim et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Higher Circulating Sphingosine 1-Phosphate Levels Are Associated with Lower Bone Mineral Density and Higher Bone Resorption Marker in Humans
- (2012) Seung Hun Lee et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary
- (2012) Hajime Orimo et al. Archives of Osteoporosis
- WHO absolute fracture risk models (FRAX): Do clinical risk factors improve fracture prediction in older women without osteoporosis?
- (2011) Teresa A Hillier et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Vertebral fracture assessment using a semiquantitative technique
- (2010) Harry K. Genant et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The diagnosis of osteoporosis
- (2010) John A. Kanis et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Evaluation of the FRAX and Garvan fracture risk calculators in older women
- (2010) Mark J Bolland et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo
- (2010) Masaru Ishii et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis
- (2009) Masaru Ishii et al. NATURE
- Significance of a decline in bone mineral density while receiving oral bisphosphonate treatment
- (2008) A SEBBA CLINICAL THERAPEUTICS
- Sphingosine-1-phosphate acts as a developmental stage specific inhibitor of platelet-derived growth factor-induced chemotaxis of osteoblasts
- (2008) T. Roelofsen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate
- (2008) L. Pederson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started